Roche does fourth China deal since August, teaming with Defand on degraders
Roche is teaming up with a relatively unknown Chinese biotech in a deal worth a tad shy of $1 billion, if all milestones are achieved, according to a source familiar with the terms. The Hangzhou ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.